Search
for

    Sort by

    Research 30 of 1000+

    1. NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders Journal of Medicinal Chemistry · 2025 · 45 citations
    2. Advancing Design Strategy of PROTACs for Cancer Therapy MedComm · 2025 · 4 citations
    3. Androgen Receptor Ligands: Agonists and Antagonists Elsevier eBooks · 2017 · 2 citations
    4. The role of nuclear hormone receptors in cutaneous wound repair Cell Biochemistry and Function · 2014 · 68 citations
    5. Role of  -catenin in Epidermal Stem Cell Expansion, Lineage Selection, and Cancer Cold Spring Harbor Symposia on Quantitative Biology · 2008 · 61 citations
    6. Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents Annals of Oncology · 2005 · 67 citations
    7. Angelica gigas Nakai (Korean Dang-gui) Root Alcoholic Extracts in Health Promotion and Disease Therapy – active Phytochemicals and In Vivo Molecular Targets Pharmaceutical Research · 2025 · 2 citations
    8. 25 years of ERβ: a personal journey Journal of molecular endocrinology · 2021 · 11 citations
    9. Transcriptome sequencing reveals the expression profiles of lncRNAs and mRNAs in goat skin tissues with different types of wool coats Scientific Reports · 2025 · 1 citations
    10. Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer Exploration of targeted anti-tumor therapy · 2021 · 2 citations
    11. Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery Journal of Medicinal Chemistry · 2025
    12. Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment Cancer · 2025 · 3 citations
    13. The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model Biology direct · 2010 · 50 citations
    14. PROTACs in 2025: from the laboratory concept to clinical breakthrough Future Medicinal Chemistry · 2026
    15. Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm Asia-Pacific Journal of Clinical Oncology · 2018 · 4 citations
    16. Androgens and androgen receptor action in skin and hair follicles Molecular and Cellular Endocrinology · 2017 · 100 citations
    17. Hormonal treatment of acne vulgaris: an update Clinical, Cosmetic and Investigational Dermatology · 2016 · 46 citations
    18. Vitamin D, Lipid Metabolism and Prostate Cancer Trepo - Institutional Repository of Tampere University · 2009 · 1 citations
    19. Redefining hormone resistance in prostate cancer Therapeutic Advances in Medical Oncology · 2009 · 38 citations
    20. Beyond acne: Current aspects of sebaceous gland biology and function Reviews in Endocrine and Metabolic Disorders · 2016 · 97 citations
    21. Androgen antagonists in androgen target tissues Pharmacology & Therapeutics · 1984 · 27 citations
    22. TMPRSS2: A Key Host Factor in SARS-CoV-2 Infection and Potential Therapeutic Target Medeniyet Medical Journal · 2025 · 4 citations
    23. Global Trends in Research of Androgen Receptor Associated With Breast Cancer From 2011 to 2020: A Scientometric Analysis Frontiers in Endocrinology · 2022 · 5 citations
    24. Androgen Receptor Blockade Induces the Phagocytosis of MRSA and Pseudomonas aeruginosa by Monocyte-Derived Macrophages In Vitro Deleted Journal · 2025
    25. Membrane androgen receptors may mediate androgen reinforcement Psychoneuroendocrinology · 2010 · 37 citations
    26. Adenosine and Its Receptors in the Pathogenesis and Treatment of Inflammatory Skin Diseases International Journal of Molecular Sciences · 2024 · 1 citations
    27. Paxillin regulates androgen receptor expression associated with granulosa cell focal adhesions Molecular Human Reproduction · 2024 · 3 citations
    28. Constitutive Internalization of the Leucine-rich G Protein-coupled Receptor-5 (LGR5) to the Trans-Golgi Network Journal of Biological Chemistry · 2013 · 58 citations
    29. Follikelhormone Springer Reference Medizin · 2019
    30. Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome Therapeutic Advances in Endocrinology and Metabolism · 2019 · 4 citations